Individualized treatment with pegylated interferon-α for chronic hepatitis B
Antiviral therapy is the basic treatment of chronic hepatitis B, and pegylated interferon-α is one of the first-line treatment drugs. At present, several consensuses have been reached on individualized treatment with pegylated interferon-α, which is playing an important role in clinical practice. Ne...
Main Author: | WAN Mobin |
---|---|
Format: | Article |
Language: | zho |
Published: |
Editorial Department of Journal of Clinical Hepatology
2018-05-01
|
Series: | Linchuang Gandanbing Zazhi |
Subjects: | |
Online Access: | http://www.lcgdbzz.org/qk_content.asp?id=8958 |
Similar Items
-
Research advances in predictors of treatment responses to pegylated interferon alpha in patients with chronic hepatitis B
by: GAO Aihua
Published: (2015-04-01) -
Impact of pegylated interferon versus conventional interferon on the change in peripheral CD4+CD25high T cells in patients with chronic hepatitis B
by: WANG Haiyan
Published: (2018-01-01) -
Effect of pegylated interferon α-2a combined with thymosin α1 on quality of life in patients with chronic hepatitis B
by: LU Jianguo
Published: (2013-12-01) -
Efficacy of pegylated interferon α-2a in HBeAg-negative chronic hepatitis B patients and its influencing factors
by: LIU Zhihua
Published: (2015-05-01) -
Expert consensus on clinical management of adverse reactions in interferon-α therapy for chronic viral hepatitis
by: Expert Committee on Clinical Management of Adverse Reactions in Interferon-α Therapy for Chronic Viral Hepatitis
Published: (2014-11-01)